These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 14985923
1. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors. Siuciak JA, Fujiwara RA. Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923 [Abstract] [Full Text] [Related]
2. Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test. Li Y, Zhu ZR, Ou BC, Wang YQ, Tan ZB, Deng CM, Gao YY, Tang M, So JH, Mu YL, Zhang LQ. Behav Brain Res; 2015 Feb 15; 279():100-5. PubMed ID: 25449845 [Abstract] [Full Text] [Related]
3. Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats. Kitagawa K, Kitamura Y, Miyazaki T, Miyaoka J, Kawasaki H, Asanuma M, Sendo T, Gomita Y. Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul 15; 380(1):59-66. PubMed ID: 19274453 [Abstract] [Full Text] [Related]
4. The behavioural effects of pramipexole, a novel dopamine receptor agonist. Maj J, Rogóz Z, Skuza G, Kołodziejczyk K. Eur J Pharmacol; 1997 Apr 11; 324(1):31-7. PubMed ID: 9137910 [Abstract] [Full Text] [Related]
5. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats. Lagos P, Scorza C, Monti JM, Jantos H, Reyes-Parada M, Silveira R, Ponzoni A. Eur Neuropsychopharmacol; 1998 May 11; 8(2):113-20. PubMed ID: 9619689 [Abstract] [Full Text] [Related]
6. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. Brocco M, Dekeyne A, Papp M, Millan MJ. Behav Pharmacol; 2006 Nov 11; 17(7):559-72. PubMed ID: 17021388 [Abstract] [Full Text] [Related]
14. Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists. Kolasiewicz W, Maj J. Pol J Pharmacol; 2001 Jul 11; 53(5):509-15. PubMed ID: 11990070 [Abstract] [Full Text] [Related]